Financials

  • Market Capitalization 641.19 M
  • Employee 146
  • Founded 2019
  • CEO N/A
  • Website www.primemedicine.com
  • Headquarter Delaware, United States
  • FIGI BBG011RT3R55
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.57
Rapporto prezzo/fatturato
111.44

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

Notizie